| 11/18/2026 7:35 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/16/2026 8:55 PM | ADAR1 Capital Management, LLC (1940272) Filed by Grace Therapeutics (1444192) Subject | Form SCHEDULE 13G/A | |
| 11/13/2026 4:07 PM | Grace Therapeutics (1444192) Subject Nantahala Capital Management, LLC (1472322) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2026 7:01 AM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2026 6:32 AM | Grace Therapeutics (1444192) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2026 8:05 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/26/2026 5:06 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2026 5:06 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2026 7:42 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 4:45 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 5:46 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GRCE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/01/2026 3:30 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 3:05 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4/A | |
| 09/23/2026 5:19 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/21/2026 3:22 PM | Grace Therapeutics (1444192) Issuer NEUGEBOREN EDWARD (1320873) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/21/2026 3:20 PM | DAVIS A BRIAN (1184432) Reporting Grace Therapeutics (1444192) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 3:06 PM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/10/2026 3:05 PM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 6:30 AM | Grace Therapeutics (1444192) Issuer Kohli Prashant (1946739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:05 PM | DelAversano Robert J (1728262) Reporting Grace Therapeutics (1444192) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:05 PM | Grace Therapeutics (1444192) Issuer Macdonald R. Loch (1653008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:05 PM | Grace Therapeutics (1444192) Issuer Kohli Prashant (1946739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:05 PM | Grace Therapeutics (1444192) Issuer Kumar Amresh (1978220) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/31/2026 11:15 PM | Grace Therapeutics (1444192) Filer | Form EFFECT | |
| 08/24/2026 3:06 PM | Grace Therapeutics (1444192) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 08/19/2026 6:44 AM | Grace Therapeutics (1444192) Issuer Opaleye Management Inc. (1595855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2026 7:01 AM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 6:30 AM | Grace Therapeutics (1444192) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/07/2026 3:05 PM | Grace Therapeutics (1444192) Subject Opaleye Management Inc. (1595855) Filed by | Form SCHEDULE 13G | |
| 08/06/2026 3:06 PM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 7:15 AM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 7:01 AM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 6:31 AM | Grace Therapeutics (1444192) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 05/15/2026 7:06 PM | ADAR1 Capital Management, LLC (1940272) Filed by Grace Therapeutics (1444192) Subject | Form SCHEDULE 13G/A | |
| 04/27/2026 7:07 AM | Grace Therapeutics (1444192) Subject HIRSCHMAN ORIN (1131362) Filed by | Form SCHEDULE 13G/A | |
| 04/27/2026 6:08 AM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 1:36 PM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 5:17 PM | ADAR1 Capital Management, LLC (1940272) Filed by Grace Therapeutics (1444192) Subject | Form SCHEDULE 13G/A | |
| 02/12/2026 7:01 AM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 6:31 AM | Grace Therapeutics (1444192) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/28/2026 1:24 PM | Grace Therapeutics (1444192) Subject HIRSCHMAN ORIN (1131362) Filed by | Form SCHEDULE 13G/A | |
This Could Be the Biggest Monetary Shift in 50 Years (Ad) The U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trades above $4,000 today.
That gap means Washington's books show about $11 billion in gold that is actually worth more than $1 trillion. A bill in Congress would require repricing those reserves at market value.
More than 60 million Americans qualify to move part of their savings into physical gold, tax-free and penalty-free, according to the 2026 Gold and Silver Guide. Request your free 2026 Gold and Silver Guide to learn more today |
| 01/12/2026 4:00 PM | Grace Therapeutics (1444192) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:01 PM | DAVIS A BRIAN (1184432) Reporting Grace Therapeutics (1444192) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:01 PM | Grace Therapeutics (1444192) Issuer NEUGEBOREN EDWARD (1320873) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:01 PM | Grace Therapeutics (1444192) Issuer Kottayil George (1895357) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:01 PM | Grace Therapeutics (1444192) Issuer Kavuru Vimal (1697184) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |